Status:
COMPLETED
The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients
Lead Sponsor:
Samsung Medical Center
Conditions:
Platelet Aggregation Inhibitors
Hydroxymethylglutaryl-coa Reductase Inhibitors
Brief Summary
A nationwide retrospective cohort study. To investigate the real world medication compliance and the relation with clinical outcomes. The persistence and compliance to dual anti-platelet therapy(DAPT...
Detailed Description
A nationwide retrospective cohort study. The persistence and compliance to dual anti-platelet therapy(DAPT) and dyslipidemia agents are important for the patients undergoing percutaneous coronary inte...
Eligibility Criteria
Inclusion
- 1\. All claim of percutaneous coronary intervention using stent in the National Healthcare Insurance Service of Korea between January 1st 2011 and December 31st, 2011
Exclusion
- No use of stents
- Stent not classified into DES or BMS
- Use of DES and BMS together at the same initial day
Key Trial Info
Start Date :
April 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2018
Estimated Enrollment :
47291 Patients enrolled
Trial Details
Trial ID
NCT03785509
Start Date
April 6 2017
End Date
November 30 2018
Last Update
December 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Gang nam-Gu, Ilwon-Dong, South Korea, 135-710